IN202011029286A - - Google Patents
Download PDFInfo
- Publication number
- IN202011029286A IN202011029286A IN202011029286A IN202011029286A IN202011029286A IN 202011029286 A IN202011029286 A IN 202011029286A IN 202011029286 A IN202011029286 A IN 202011029286A IN 202011029286 A IN202011029286 A IN 202011029286A IN 202011029286 A IN202011029286 A IN 202011029286A
- Authority
- IN
- India
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202011029286A IN202011029286A (en) | 2020-07-10 | 2020-07-10 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202011029286A IN202011029286A (en) | 2020-07-10 | 2020-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN202011029286A true IN202011029286A (en) | 2020-10-09 |
Family
ID=85173770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN202011029286A IN202011029286A (en) | 2020-07-10 | 2020-07-10 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN202011029286A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112694434A (en) * | 2020-12-29 | 2021-04-23 | 浙江和泽医药科技股份有限公司 | New lefenacin intermediate, active electrophilic building block thereof and new preparation method of lefenacin |
| CN112830890A (en) * | 2020-12-03 | 2021-05-25 | 上海谷森医药有限公司 | Preparation method of lefenacin intermediate and lefenacin |
| CN114276290A (en) * | 2021-12-24 | 2022-04-05 | 浙江和泽医药科技股份有限公司 | Rifenacin anhydrous crystal form and preparation method thereof |
| CN114573500A (en) * | 2021-04-20 | 2022-06-03 | 扬州中宝药业股份有限公司 | Preparation method of lefenacin intermediate |
| WO2023002502A1 (en) * | 2021-07-17 | 2023-01-26 | Msn Laboratories Private Ltd, R&D Center | Novel process for the preparation of 1-(2-{4-[(4-carbamoylpiperidin-1-yl)methyl]- n-methylbenzamido}ethyl)piperidin-4-yl n-({1,1'-biphenyl}-2-yl)carbamate |
| WO2023104920A1 (en) | 2021-12-09 | 2023-06-15 | Medichem, S.A. | Crystalline acetone solvate of revefenacin |
| CN117180235A (en) * | 2023-09-19 | 2023-12-08 | 山东京卫制药有限公司 | A kind of amorphous raphenacin inhalation preparation |
| CN117285458A (en) * | 2023-09-19 | 2023-12-26 | 山东京卫制药有限公司 | Amorphous Lei Fen narasin and preparation method thereof |
| CN118750472A (en) * | 2024-06-13 | 2024-10-11 | 朗天药业(湖北)有限公司 | A kind of revenacin inhalation solution and preparation method |
| WO2024230602A1 (en) * | 2023-05-09 | 2024-11-14 | 四川科伦药物研究院有限公司 | Crystal form of muscarine antagonist, method for preparing same, and use thereof |
-
2020
- 2020-07-10 IN IN202011029286A patent/IN202011029286A/en unknown
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112830890A (en) * | 2020-12-03 | 2021-05-25 | 上海谷森医药有限公司 | Preparation method of lefenacin intermediate and lefenacin |
| CN112694434A (en) * | 2020-12-29 | 2021-04-23 | 浙江和泽医药科技股份有限公司 | New lefenacin intermediate, active electrophilic building block thereof and new preparation method of lefenacin |
| CN112694434B (en) * | 2020-12-29 | 2023-06-16 | 浙江和泽医药科技股份有限公司 | New intermediate of raffinacine and new preparation method of active electrophilic building block and Lei Fen finacine thereof |
| CN114573500A (en) * | 2021-04-20 | 2022-06-03 | 扬州中宝药业股份有限公司 | Preparation method of lefenacin intermediate |
| CN114573500B (en) * | 2021-04-20 | 2024-02-20 | 扬州中宝药业股份有限公司 | Preparation method of raffinancin intermediate |
| WO2023002502A1 (en) * | 2021-07-17 | 2023-01-26 | Msn Laboratories Private Ltd, R&D Center | Novel process for the preparation of 1-(2-{4-[(4-carbamoylpiperidin-1-yl)methyl]- n-methylbenzamido}ethyl)piperidin-4-yl n-({1,1'-biphenyl}-2-yl)carbamate |
| WO2023104920A1 (en) | 2021-12-09 | 2023-06-15 | Medichem, S.A. | Crystalline acetone solvate of revefenacin |
| CN114276290A (en) * | 2021-12-24 | 2022-04-05 | 浙江和泽医药科技股份有限公司 | Rifenacin anhydrous crystal form and preparation method thereof |
| CN114276290B (en) * | 2021-12-24 | 2024-05-28 | 浙江和泽医药科技股份有限公司 | Rafenacin anhydrous crystal form and preparation method thereof |
| WO2024230602A1 (en) * | 2023-05-09 | 2024-11-14 | 四川科伦药物研究院有限公司 | Crystal form of muscarine antagonist, method for preparing same, and use thereof |
| CN117180235A (en) * | 2023-09-19 | 2023-12-08 | 山东京卫制药有限公司 | A kind of amorphous raphenacin inhalation preparation |
| CN117285458A (en) * | 2023-09-19 | 2023-12-26 | 山东京卫制药有限公司 | Amorphous Lei Fen narasin and preparation method thereof |
| CN118750472A (en) * | 2024-06-13 | 2024-10-11 | 朗天药业(湖北)有限公司 | A kind of revenacin inhalation solution and preparation method |